Atossa Genetics ROE 2012-2025 | ATOS
Current and historical return on equity (ROE) values for Atossa Genetics (ATOS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Atossa Genetics ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $-0.03B | $0.06B | -41.79% |
| 2025-03-31 | $-0.03B | $0.07B | -35.86% |
| 2024-12-31 | $-0.03B | $0.07B | -32.15% |
| 2024-09-30 | $-0.03B | $0.07B | -32.63% |
| 2024-06-30 | $-0.03B | $0.08B | -29.30% |
| 2024-03-31 | $-0.03B | $0.09B | -31.58% |
| 2023-12-31 | $-0.03B | $0.09B | -29.48% |
| 2023-09-30 | $-0.03B | $0.10B | -26.73% |
| 2023-06-30 | $-0.03B | $0.11B | -26.96% |
| 2023-03-31 | $-0.03B | $0.11B | -23.09% |
| 2022-12-31 | $-0.03B | $0.12B | -21.30% |
| 2022-09-30 | $-0.03B | $0.12B | -18.98% |
| 2022-06-30 | $-0.02B | $0.13B | -16.18% |
| 2022-03-31 | $-0.02B | $0.14B | -15.77% |
| 2021-12-31 | $-0.02B | $0.14B | -14.92% |
| 2021-09-30 | $-0.03B | $0.14B | -24.78% |
| 2021-06-30 | $-0.03B | $0.14B | -32.40% |
| 2021-03-31 | $-0.02B | $0.14B | -49.73% |
| 2020-12-31 | $-0.02B | $0.03B | -157.14% |
| 2020-09-30 | $-0.01B | $0.01B | -123.81% |
| 2020-06-30 | $-0.01B | $0.01B | -110.64% |
| 2020-03-31 | $-0.02B | $0.01B | -112.28% |
| 2019-12-31 | $-0.02B | $0.01B | -104.62% |
| 2019-09-30 | $-0.02B | $0.02B | -104.92% |
| 2019-06-30 | $-0.02B | $0.02B | -112.28% |
| 2019-03-31 | $-0.03B | $0.02B | -188.68% |
| 2018-12-31 | $-0.02B | $0.01B | -235.90% |
| 2018-09-30 | $-0.02B | $0.01B | -248.65% |
| 2018-06-30 | $-0.02B | $0.01B | -303.45% |
| 2018-03-31 | $-0.01B | $0.01B | -244.44% |
| 2017-12-31 | $-0.01B | $0.01B | -293.33% |
| 2017-09-30 | $-0.01B | $0.00B | -436.36% |
| 2017-06-30 | $-0.01B | $0.00B | -307.69% |
| 2017-03-31 | $-0.01B | $0.00B | -233.33% |
| 2016-12-31 | $-0.01B | $0.00B | -200.00% |
| 2016-09-30 | $-0.01B | $0.01B | -240.00% |
| 2016-06-30 | $-0.01B | $0.00B | -273.68% |
| 2016-03-31 | $-0.01B | $0.00B | -186.67% |
| 2015-12-31 | $-0.02B | $0.00B | -166.67% |
| 2015-09-30 | $-0.02B | $0.01B | -156.10% |
| 2015-06-30 | $-0.02B | $0.01B | -127.66% |
| 2015-03-31 | $-0.02B | $0.01B | -115.38% |
| 2014-12-31 | $-0.01B | $0.01B | -88.89% |
| 2014-09-30 | $-0.01B | $0.02B | -67.69% |
| 2014-06-30 | $-0.01B | $0.02B | -77.42% |
| 2014-03-31 | $-0.01B | $0.02B | -92.31% |
| 2013-12-31 | $-0.01B | $0.01B | -126.32% |
| 2013-09-30 | $-0.01B | $0.01B | -137.50% |
| 2013-06-30 | $-0.01B | $0.01B | -139.13% |
| 2013-03-31 | $-0.01B | $0.01B | -160.00% |
| 2012-12-31 | $-0.01B | $0.01B | -250.00% |
| 2012-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.106B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.059B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $200.747B | 78.54 |
| IDEXX Laboratories (IDXX) | United States | $56.571B | 56.18 |
| Edwards Lifesciences (EW) | United States | $48.391B | 32.45 |
| Alcon (ALC) | Switzerland | $36.485B | 24.49 |
| IQVIA Holdings (IQV) | United States | $35.841B | 19.99 |
| Mettler-Toledo (MTD) | United States | $29.649B | 34.40 |
| STERIS (STE) | Ireland | $25.888B | 26.72 |
| Waters (WAT) | United States | $22.128B | 29.27 |
| DexCom (DXCM) | United States | $21.451B | 29.57 |
| Hologic (HOLX) | United States | $16.481B | 17.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.721B | 0.00 |
| Globus Medical (GMED) | United States | $11.330B | 23.57 |
| Penumbra (PEN) | United States | $10.425B | 73.33 |
| Masimo (MASI) | United States | $7.690B | 24.64 |
| Sysmex ADR (SSMXY) | Japan | $6.698B | 21.28 |
| Teleflex (TFX) | United States | $4.835B | 7.70 |
| Glaukos (GKOS) | United States | $4.816B | 0.00 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.296B | 37.57 |
| Alphatec Holdings (ATEC) | United States | $2.941B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 14.88 |
| Integer Holdings (ITGR) | United States | $2.392B | 11.23 |
| Artivion (AORT) | United States | $2.117B | 97.54 |
| Nihon Kohden (NHNKY) | Japan | $2.067B | 24.67 |
| PROCEPT BioRobotics (PRCT) | United States | $1.784B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.686B | 16.34 |
| Beta Bionics (BBNX) | United States | $1.158B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.099B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.11 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.680B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.555B | 32.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.521B | 10.40 |
| AngioDynamics (ANGO) | United States | $0.495B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.427B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.418B | 11.59 |
| Semler Scientific (SMLR) | United States | $0.418B | 3.28 |
| RxSight (RXST) | United States | $0.385B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.327B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Sight Sciences (SGHT) | United States | $0.305B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.294B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.265B | 0.00 |
| CVRx (CVRX) | United States | $0.255B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Neuronetics (STIM) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.127B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.54 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |